• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

VivoSim Labs, Inc. - Common Stock (NQ:VIVS)

0.3819 -0.0079 (-2.03%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 584,626
Open 0.3800
Bid (Size) 0.3667 (100)
Ask (Size) 0.3788 (600)
Prev. Close 0.3898
Today's Range 0.3615 - 0.3850
52wk Range 0.3612 - 5.300
Shares Outstanding 8,716,953
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
In today's session, these stocks are experiencing unusual volume. ↗
July 21, 2026
Via Chartmill
MissionIRNewsBreaks – VivoSim Labs, Inc. (NASDAQ: VIVS) Announces $4 Million Private Placement
July 21, 2026
Via Investor Brand Network
Topics Animal Testing

Performance

YTD
-79.7%
-79.7%
1 Month
-64.0%
-64.0%
3 Month
-74.5%
-74.5%
6 Month
-77.9%
-77.9%
1 Year
-82.7%
-82.7%

More News

Read More
News headline image
VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services
July 21, 2026
From VivoSim Labs, Inc.
Via GlobeNewswire
In today's session, these stocks are experiencing unusual volume. ↗
July 16, 2026
Via Chartmill
Thursday's session: top gainers and losers ↗
July 16, 2026
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
July 16, 2026
Via Chartmill
News headline image
VivoSim Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Healthcare Focused Institutional Investor
July 16, 2026
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027
July 15, 2026
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
VivoSim Presents Data Showing Superiority to Competition in NAM Liver Tox Prediction at European Toxicology Meeting
June 29, 2026
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
VivoSim Platform Predicts Gastrointestinal Toxicity (Diarrhea) in an AI Model Trained on Human Intestinal Model Results – Without Animal Testing
April 28, 2026
From VivoSim Labs, Inc.
Via GlobeNewswire
Which stocks are moving before the opening bell on Wednesday? ↗
April 01, 2026
Via Chartmill
News headline image
VivoSim Announces Pricing of up to a $4 Million Public Offering
April 01, 2026
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCs
March 24, 2026
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales
March 03, 2026
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
VivoSim to Debut Antibody Drug Conjugate Data, representing a major new market for NAMkind models, at Society of Toxicology Meeting in San Diego
February 11, 2026
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
Why Is VIVS Stock Up 79% Today? ↗
January 30, 2026
Via Stocktwits
Topics Animal Testing
Let's take a look at the stocks that are in motion in today's session. ↗
January 30, 2026
Via Chartmill
Check out the stocks that are attracting the most attention and driving market activity. ↗
January 30, 2026
Via Chartmill
Top movers analysis in the middle of the day on 2026-01-30: top gainers and losers in today's session. ↗
January 30, 2026
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
January 30, 2026
Via Chartmill
News headline image
VivoSim Expands Asia-Pacific Access to NAMKind™ Human-Based Toxicology Services Through New Distributor Agreement in Korea and China
January 29, 2026
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer
January 06, 2026
From VivoSim Labs, Inc.
Via GlobeNewswire
News headline image
These stocks are moving in today's session ↗
October 30, 2025
Via Chartmill
News headline image
Roadzen Inc. (NASDAQ: RDZN) Accelerates U.S. Expansion with Strategic Acquisition – Surges on Record Volume – More Stocks Inside
October 30, 2025
Via AB Newswire
Topics Artificial Intelligence
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
October 30, 2025
Via Benzinga

Frequently Asked Questions

Is VivoSim Labs, Inc. - Common Stock publicly traded?
Yes, VivoSim Labs, Inc. - Common Stock is publicly traded.
What exchange does VivoSim Labs, Inc. - Common Stock trade on?
VivoSim Labs, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for VivoSim Labs, Inc. - Common Stock?
The ticker symbol for VivoSim Labs, Inc. - Common Stock is VIVS on the Nasdaq Stock Market
What is the current price of VivoSim Labs, Inc. - Common Stock?
The current price of VivoSim Labs, Inc. - Common Stock is 0.3819
When was VivoSim Labs, Inc. - Common Stock last traded?
The last trade of VivoSim Labs, Inc. - Common Stock was at 07/28/26 04:00 PM ET
What is the market capitalization of VivoSim Labs, Inc. - Common Stock?
The market capitalization of VivoSim Labs, Inc. - Common Stock is 3.33M
How many shares of VivoSim Labs, Inc. - Common Stock are outstanding?
VivoSim Labs, Inc. - Common Stock has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap